课题基金 / 基金详情

Defining and preventing the mechanisms responsible for disulphide bond reduction of monoclonal antibodies during bioprocessing

Defining and preventing the mechanisms responsible for disulphide bond reduction of monoclonal antibodies during bioprocessing
定义和防止生物加工过程中单克隆抗体二硫键还原的机制
批准号:
BB/I015876/1
负责人:
Christopher Smales
金额:
$11.71万
依托单位:
依托单位国家:
英国
项目类别:
Training Grant
财政年份:
2011
资助国家:
英国
项目状态:
已结题
起止时间:
2011 至 --

项目摘要

项目成果

Christopher Smales的其他基金

相似基金

相关文献

中文摘要
翻译
哺乳动物细胞(特别是中国仓鼠卵巢)已经成为产生IgG治疗性抗体的主要系统,因为它们能够产生正确折叠和组装的异源蛋白,以及它们的翻译后修饰能力。这种IgG抗体发挥功能的先决条件是它们正确地组装成确定的四级结构,由两条重链(HC)和两条轻链(LC)多肽组成,形成二硫键结合的HC2LC2分子。折叠、组装和翻译后修饰发生在内质网内,分子在被运送到高尔基体之前受到严格的质量控制。IgG多肽依次与内质网复合体内的一系列分子伴侣、折叠酶和氧化还原酶相互作用。LC多肽既可以作为单体分泌,也可以作为二硫键二聚体分泌。相反,HC多肽的分泌需要LC的存在,LC的缺失导致HC多肽在内质网内保持未折叠状态,然后被转运到蛋白酶体进行降解。据报道,生化和生理刺激对内质网施加压力,导致细胞内未折叠或错误折叠的蛋白质积累。此外,与先前报道的结果相反,龙沙产生的数据显示,在收获时暴露于低氧条件下的培养液中存在HC单体和二聚体。游离的LC和HC单体和二聚体的存在是不希望的,需要确定它们的衍生机制和避免它们存在的方法。还需要了解生物反应器中理化参数的变化与内质网分泌错误折叠/未折叠蛋白质的分子机制之间的关系,以及细胞培养上清对充分分泌抗体的结构和稳定性的影响。提议的工作方案。该学生将使用分子和细胞生物学技术的组合来开发方法,以防止IgG1和IgG4亚型的二硫键减少。最初的研究将使用产生二硫键还原产物的细胞系(和产品)。这些细胞系将用于建立一个实验室规模的测试系统,可以为分析提供材料。然后,学生将确定(a)在不同的物理化学条件下导致错误折叠/未折叠蛋白质分泌的细胞内因素(即通过克服ERAD途径使错误折叠/未折叠蛋白质分泌的因素)和(b)细胞培养过程中产生更容易受到二硫键还原/改组的细胞培养上清的关键因素(即定义上清中发生的还原/改组过程)post-secretion)。该信息将用于鉴定细胞培养上清中的特定标记物,这些标记物可以确定抗体在开始收获和下游加工之前解离的倾向。博士学位的成果将是:1。建立在还原条件下导致错误折叠蛋白(游离HC/LC)分泌的关键细胞内因子的分子模型(IgG1和IgG4亚型之间是否存在差异,宿主细胞系之间有何差异?)2.鉴定细胞培养上清中催化二硫键还原的还原性成分。3.鉴定细胞培养过程中产生上清更容易受到二硫键还原/洗选的因素(如培养基、溶解氧张力、温度、pH值、过滤、离心、细胞总蛋白)。4.鉴定细胞培养上清中的标记物,确定抗体在开始收获和下游加工步骤(如凋亡,还原酶活性)之前解离的倾向。
英文摘要
Mammalian cells (particularly Chinese hamster ovary) have become the dominant system for the production of IgG based therapeutic antibodies due to their ability to produce properly folded and assembled heterologous proteins as well as their capability for post translational modifications. A prerequisite for the function of such IgG antibodies is their correct assembly into defined quaternary structures, composed of two heavy chain (HC) and two light chain (LC) polypeptides that form disulphide bonded HC2LC2 molecules. Folding, assembly and post-translational modifications occur within the ER where the molecule is subjected to rigorous quality control before being transported to the Golgi. IgG polypeptides sequentially interact with a range of molecular chaperones, foldases and oxioreductases present within the ER complex. The LC polypeptide can be secreted as both monomer and disulphide bonded dimer. Conversely, HC polypeptide secretion requires the presence of LC for secretion, the absence of which results in the HC polypeptide being retained in an unfolded state within the ER before being trafficked to the proteasome for degradation. Biochemical and physiological stimuli have been reported to impose stress on the ER and lead to the accumulation of unfolded or misfolded proteins within the cell. In addition, contrary to previously reported results, data generated at Lonza have shown the presence of HC monomer and dimer in culture broths exposed to low oxygen conditions at harvest. The presence of free LC and HC monomers and dimers is undesirable and defining the mechanism(s) by which these are derived and approaches to avoid the presence of these is required. There is also a need to understand the relationship between changes in physiochemical parameters in the bioreactor and the molecular mechanisms allowing the secretion of misfolded/unfolded proteins from the ER and the influence of cell culture supernatant on the structure and stability of fully secreted antibody. Proposed work programme. The student will use a combination of molecular and cell biology techniques to develop methods to prevent disulphide bond reduction in both IgG1 and IgG4 subtypes. Initial studies will use cell lines (and product) that yield disulphide bond reduction products. These cell lines will be used to establish a laboratory scale test system that can provide material for analysis. The student will then identify (a) intra-cellular factors that cause the secretion of misfolded/unfolded proteins under different physiochemical conditions (i.e. factors that enable the secretion of misfolded/unfolded proteins by overcoming the ERAD pathway) and (b) key factors in cell culture processes that yield cell culture supernatant that is more susceptible to disulphide bond reduction/shuffling (i.e. define those reductions/shuffling processes that occur in the supernatant post-secretion). This information will be used to identify specific markers within cell culture supernatant that can determine the propensity of antibodies to dissociate prior to initiation of harvest and downstream processing. The outcomes of the PhD will be: 1.Establishment of a molecular model of the key intra-cellular factors that cause the secretion of mis-folded proteins (free HC/LC) under reducing conditions (are there differences between IgG1 and IgG4 subtypes, how does this differ between host cell lines?). 2.Identification of reducing components in cell culture supernatant that catalyze the reduction of disulphide bonds. 3.Identification of factors in cell culture processes that yield supernatant more susceptible to disulphide bond reduction/shuffling (e.g. media, dissolved oxygen tension, temperature, pH, filtration, centrifugation, total cellular protein). 4.Identification of markers within cell culture supernatant that determine the propensity of antibodies to dissociate prior to initiation of harvest and downstream processing steps (e.g. apoptosis, activity of reducing enzymes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Taiwan Partnering Award: Establishing a CHO Cell Expression System for Animal Vaccine Production
  • 批准号:
    BB/T01945X/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $3.09万
  • 财政年份:
    2021
  • 负责人:
    Christopher Smales
  • 依托单位:
Generation, characterisation and application of SARS-CoV-2 protein antigens for COVID-19 rapid diagnostic purposes in the hospital and community
  • 批准号:
    BB/V011324/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $53.26万
  • 财政年份:
    2020
  • 负责人:
    Christopher Smales
  • 依托单位:
An integrated cell and protein engineering approach to generate enhanced CHO cell platforms for manufacture of difficult to express biopharmaceuticals
  • 批准号:
    BB/R001731/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $43.65万
  • 财政年份:
    2018
  • 负责人:
    Christopher Smales
  • 依托单位:
Translation of Step-changing Bioprocesses and Expression System Technologies for Next Generation Protein Biologics Production in CHO Cells
  • 批准号:
    BB/N023501/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $95.09万
  • 财政年份:
    2016
  • 负责人:
    Christopher Smales
  • 依托单位:
海外基金